SavedAdd your journal

Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 1

Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?

Hüseyin Onur AYDIN
Tevfik AVCI
Gökhan MORAY
Hakan YABANOĞLU
Erdal KARAGÜLLE
Ali HARMAN
Pages
113–119
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Five (7.4%) patients died.Conclusion: Percutaneous cholecystostomy catheter is an effective treatment to control inflammation until cholecystectomy among high-risk patients diagnosed with severe cholecystitis and may be a definitive therapy for patients unable to undergo surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The medical records of 68 patients diagnosed with severe ACC and treated with PC at Başkent University Faculty of Medicine, General Surgery Clinic between January 2011 and January 2018 were retrospectively analyzed.Results: Among patients who underwent PC for severe ACC at our clinic, 39 (57.4%) were male.
📊
Key Findings & Data:Their mean age was 71.7 (28-94) years.
💡
Conclusion & Impact:Five (7.4%) patients died.Conclusion: Percutaneous cholecystostomy catheter is an effective treatment to control inflammation until cholecystectomy among high-risk patients diagnosed with severe cholecystitis and may be a definitive therapy for patients unable to undergo surgery.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The medical records of 68 patients diagnosed with severe ACC and treated with PC at Başkent University Faculty of Medicine, General Surgery Clinic between January 2011 and January 2018 were retrospectively analyzed.Results: Among patients who underwent PC for severe ACC at our clinic, 39 (57.4%) were male. Their mean age was 71.7 (28-94) years. All patients had pain; 13 (19.1%) patients had nausea-vomiting; 8 (11.8%) had had fever. The mean time from symptom onset to hospital admission was 6.2 (1-30) days; the mean time from admission to PC placement was 2.1 (1-9) days. Twelve (17.6%) patients had minor complications due to cholecystostomy catheter. Twenty seven (39.7%) patients underwent cholecystectomy with a mean of 83.1 (20-705) days after cholecystostomy placement. Seventeen of these patients underwent laparoscopic surgery and 3 of them converted to open surgery. In 5 of 41 patients who did not undergo cholecystectomy, AC recurrence developed (12.2%) and PC was inserted again. Five (7.4%) patients died.Conclusion: Percutaneous cholecystostomy catheter is an effective treatment to control inflammation until cholecystectomy among high-risk patients diagnosed with severe cholecystitis and may be a definitive therapy for patients unable to undergo surgery.

🔖

Cite This Article

AYDIN, H. O., AVCI, T., MORAY, G., YABANOĞLU, H., KARAGÜLLE, E., HARMAN, A. (2022). Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. Annals of Medical Research, Cilt: 28 - Sayı: 1, 113–119. https://ajindex.com/articles/445975

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Everhart JE, Khare M, Hill M, et al. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999;117:632–9
  2. Gerard J, Luu MB, Poirier J, et al. Acute cholecystitis: comparing clinical outcomes with TG13 severity and intended laparoscopic versus open cholecystectomy in difficult operative cases. Surg Endosc 2018;32:3943- 8
  3. Charrier T, Kepenekian V, Muller A, et al. Management after Percutaneous Cholecystostomy: What Should We do with the Catheter? Surg Laparosc Endosc Percutaneous Tech 2018;28:256-60
  4. Hirota M, Takada T, Kawarada Y, et al. Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007;14:78–82
  5. Yokoe M, Takada T, Strasberg SM, et al. TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 2013;20:35–46
  6. Yamashita Y, Takada T, Strasberg SM, et al. TG13 surgical management of acute cholecystitis. J Hepatobiliary Pancreat Sci 2013;20:89–96
  7. Miura F, Takada T, Strasberg SM, et al. TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2013;20:47–54
  8. Atar E, Bachar GN, Berlin S, et al. Percutaneous cholecystostomy in critically ill patients with acute cholecystitis: Complications and late outcome. Clin Radiol 2014;69:e247–e252
  9. Nasim S, Khan S, Alvi R, et al. Emerging indications for percutaneous cholecystostomy for the management of acute cholecystitis - A retrospective review. Int J Surg 2011;9:456–9
  10. Cherng N, Witkowski ET, Sneider EB, et al. Use of cholecystostomy tubes in the management of patients with primary diagnosis of acute cholecystitis. J Am Coll Surg 2012;214:196–201
  11. Ozyer U. Long-term results of percutaneous cholecystostomy for definitive treatment of acute acalculous cholecystitis: A 10-year single-center experience. Acta Gastroenterol Belg 2018;81:393-7
  12. Kirkegård J, Horn T, Christensen SD, et al. Percutaneous cholecystostomy is an effective definitive treatment option for acute acalculous cholecystitis. Scand J Surg 2015;104:238-43
  13. Pang KW, Tan CHN, Loh S, et al. Outcomes of Percutaneous Cholecystostomy for Acute Cholecystitis. World J Surg 2016;40:2735-44
  14. Kortram K, van Ramshorst B, Bollen TL, et al. Acute cholecystitis in high risk surgical patients: Percutaneous cholecystostomy versus laparoscopic cholecystectomy (CHOCOLATE trial): Study protocol for a randomized controlled